EDGAR Filing Documents for 0001104659-15-081123

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001104659-15-081123

Filing Date

2015-11-24

Accepted

2015-11-24 16:15:55

Documents

Period of Report

2015-11-23

Document Format Files

Seq	Description	Document	Type	Size
1	4	a4.html	4
1	4	a4.xml	4	3057
	Complete submission text file	0001104659-15-081123.txt		4435

Mailing Address C/O ALLIQUA, INC. 850 THIRD AVENUE, SUITE 1801 NEW YORK NY 10022

Business Address

Type: 4 | Act: 34 | File No.: 001-36856 | Film No.: 151252907

Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837

Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000

ContraVir Pharmaceuticals, Inc. (Issuer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations